Control Bionics Limited (ASX:CBL)
Australia
· Delayed Price · Currency is AUD 0.0560
-0.0030 (-5.08%)
At close: Mar 9, 2026
Control Bionics Revenue
Control Bionics had revenue of 2.82M AUD in the half year ending December 31, 2025, a decrease of -4.86%. This brings the company's revenue in the last twelve months to 6.07M, up 14.88% year-over-year. In the fiscal year ending June 30, 2025, Control Bionics had annual revenue of 6.14M with 14.84% growth.
Revenue (ttm)
6.07M
Revenue Growth
+14.88%
P/S Ratio
3.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.07M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CurveBeam AI | 12.15M |
| Atomo Diagnostics | 3.92M |
| ImpediMed | 14.23M |
| CONNEQT Health | 5.80M |
| Memphasys | 213.98K |
| OncoSil Medical | 3.72M |
| CleanSpace Holdings | 20.66M |
| Nova Eye Medical | 33.05M |